The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $13.50

Today's change-0.47 -3.36%
Updated August 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Ironwood Pharmaceuticals Inc

Nasdaq: IRWD
Last

(U.S.) $13.50

Today's change-0.47 -3.36%
Updated August 24 4:00 PM EDT. Delayed by at least 15 minutes.

Ironwood Pharmaceuticals Inc crosses below 20-day moving average

Ironwood Pharmaceuticals Inc closed sharply lower Wednesday, dropping (U.S.)$0.47 or 3.36% to (U.S.)$13.50 and crossing below its 20-day moving average. Over the last five days, shares have gained 0.75% and 16.48% year to date. Shares have outperformed the S&P 500 by 10.91% during the last year.

Key company metrics

  • Open(U.S.) $13.98
  • Previous close(U.S.) $13.97
  • High(U.S.) $14.17
  • Low(U.S.) $13.47
  • Bid / Ask(U.S.) $9.13 / (U.S.) $0.00
  • YTD % change+16.48%
  • Volume1,314,583
  • Average volume (10-day)887,961
  • Average volume (1-month)1,172,992
  • Average volume (3-month)1,385,790
  • 52-week range(U.S.) $7.35 to (U.S.) $14.78
  • Beta1.59
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.67
Updated August 24 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue54665340
Total other revenue--------
Total revenue54665340
Gross profit54665340
Total cost of revenue0000
Total operating expense70685966
Selling / general / administrative37363230
Research & development32322826
Depreciation / amortization1------
Interest expense (income), net operating--------
Unusual expense (income)0--09
Other operating expenses, total--------
Operating income-15-2-6-26
Interest income (expense), net non-operating-10-10-10-10
Gain (loss) on sale of assets--------
Other--------
Income before tax-22-13-14-47
Income after tax-22-13-14-47
Income tax, total--------
Net income-22-13-14-47
Total adjustments to net income--------
Net income before extra. items-22-13-14-47
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-22-13-14-47
Inc. avail. to common incl. extra. items-22-13-14-47
Diluted net income-22-13-14-47
Dilution adjustment------0
Diluted weighted average shares145144143142
Diluted EPS excluding extraordinary itemsvalue per share-0.15-0.09-0.10-0.33
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.15-0.09-0.10-0.27